## AMZN: Amazon.com, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -4.0% below STRENGTH zone (4.0-10.0%); PEG 1.97 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($215.21)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Here is What to Know Beyond Why Amazon.com, Inc. (AMZN) is a Trending Stock**
- Source: Yahoo Finance Singapore | 20251209T140745 | Somewhat-Bullish | Relevance: 99%
-  This article analyzes Amazon.com, Inc. (AMZN)'s stock performance and future prospects beyond its trending status. It delves into earnings estimate revisions, revenue growth forecasts, and valuation, concluding that Amazon's Zacks Rank #2 (Buy) suggests potential outperformance in the near term. The analysis utilizes Zacks' proprietary tools to assess the company's financial health.

**2. Blue Current Inc Closes More Than $80M Series D Extension Funding Round, Anchored by Amazon, to Deliver Industry-Leading Solid-State Batteries for Stationary Storage and Mobility Applications**
- Source: Batteries News | 20251208T180821 | Bullish | Relevance: 99%
-  Blue Current Inc. has closed an $80 million Series D extension funding round, led by Amazon, with participation from Koch Disruptive Technologies, Piedmont Capital, Rusheen Capital Partners, and Allen & Company. This funding will accelerate the commercialization of Blue Current's silicon composite battery platform, designed for best-in-class safety and performance in mobility and stationary storage applications. James Hamilton, Amazon Senior Vice President, will join Blue Current's Board of Directors.

**3. Why KeyBanc Remains Bullish on Amazon (AMZN) After AWS re:Invent**
- Source: Finviz | 20251209T165545 | Bullish | Relevance: 98%
-  KeyBanc analysts reiterated an "Overweight" rating on Amazon (AMZN) with a $303.00 price target after AWS re:Invent, citing confidence in AWS momentum and long-term AI growth. The firm is encouraged by Amazon's flexible AI offerings and expects 21% year-over-year growth for AWS into 2026E. While optimistic about AMZN, KeyBanc suggests other AI stocks might offer greater upside and less downside risk.

**4. Blue Current Inc. Closes More Than $80M Series D Extension Funding Round, Anchored by Amazon, to Deliver Industry-Leading Solid-State Batteries for Stationary Storage and Mobility Applications**
- Source: The AI Journal | 20251208T160338 | Bullish | Relevance: 97%
-  Blue Current Inc. has successfully closed an over $80 million Series D extension funding round, with Amazon.com, Inc. as the anchor investor. This funding will accelerate the commercialization of Blue Current's silicon composite solid-state battery platform, designed to offer superior safety and performance for both mobility and stationary storage applications. James Hamilton, Amazon Senior Vice President and Distinguished Engineer, will join Blue Current's Board of Directors as part of this investment.

**5. Piper Sandler Keeps Overweight on Amazon (AMZN), Sets $233 Target Ahead of Holiday Season and AWS Momentum**
- Source: Finviz | 20251206T111632 | Bullish | Relevance: 97%
-  Piper Sandler has reiterated an Overweight rating on Amazon (AMZN) with a $233 price target, citing promising holiday season spending and strong AWS product momentum. The firm noted solid Black Friday to Cyber Monday growth and anticipates a 5% increase in total holiday season spend. Additionally, Piper Sandler was impressed by AWS CEO Garmanâ€™s re:Invent keynote, highlighting the arrival of the Agentic platform era.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Rosenblatt | $305 | $305 | 0% |
| 2025-12-03 | Wedbush | $340 | $340 | 0% |
| 2025-12-03 | Citizens | $300 | $300 | 0% |
| 2025-12-03 | B of A Securiti | $303 | $272 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Rosenblatt | main | Buy |
| 2025-12-03 | Wedbush | reit | Outperform |
| 2025-12-03 | Citizens | reit | Market Outperform |
| 2025-12-03 | B of A Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.00M) |
| Sells | 21 ($13.55M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 30.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 8.0% (+0.1%)
- Blackrock Inc.: 6.8% (+1.3%)
- State Street Corpora: 3.6% (+2.0%)
- JPMORGAN CHASE & CO: 3.4% (+89.5%)
- FMR, LLC: 3.1% (-4.4%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.0% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $14M sold (21 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.97 elevated, pricing in significant growth expectations. Forward P/E 28.9x stretched relative to 12% growth. Quality metrics strong (ROE 24%). Analyst sentiment positive (3 raises, avg +6%). Insider selling cluster ($13.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2425.5B |
| Beta | 1.37 |
| 52W Range | $161.38 - $258.60 |
| Short Interest | 0.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.97 |
| Forward P/E | 28.9 |
| Current P/E | 32.2 |
| YoY Growth | 11.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -2.0% to -4.0% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.0pp (needs >4.0% for momentum thesis). Underperforming sector by 3.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). RSI neutral at 45.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.04% (CS: 23) | Weak |
| RSI_14 | 45.3 | Neutral |
| MACD Histogram | -0.42 | Bearish |
| vs SMA20 | 0.979x | Below |
| vs SMA50 | 0.993x | Below |
| vs SMA200 | 1.056x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $226.89
- **Stop Loss:** $215.21 (5.1% risk)
- **Target:** $238.57 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 42
- **Position Value:** $9,529.38
- **Portfolio %:** 9.53%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-05 (Est: $1.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.56 | $1.95 | +25.2% |
| 2025Q2 | $1.33 | $1.68 | +26.1% |
| 2025Q1 | $1.36 | $1.59 | +17.1% |
| 2024Q4 | $1.48 | $1.86 | +25.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*